Psychiatric Disorders in Child and Adolescent Offspring of Parents with Schizophrenia and Bipolar Disorders.
Launched by ASSIUT UNIVERSITY · Mar 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how children and teenagers whose parents have schizophrenia or bipolar disorder might be affected by these conditions. Researchers want to understand the risks and development of mood disorders and schizophrenia in young people, especially since having a parent with these disorders can increase the chances of developing similar issues. The study aims to gather more information about this at a time when young people are growing and changing, which is crucial for identifying and supporting those who may be at risk.
To participate in this study, children and teenagers between the ages of 6 and 18 who have parents with schizophrenia or mood disorders may be eligible. Participants should have an IQ above 70, which means they can understand questions and tasks during the study. The trial is not yet recruiting participants, but once it starts, those involved can expect to share their experiences and undergo assessments to help researchers learn more about the connections between family history and mental health. This information could be important for better understanding and supporting young people in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - 6_18 years IQ \> 70 parents of schizophrenia \& mood disorders .
- Exclusion Criteria:
- • age \<6 or \>18 IQ \< 70 .
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported